Synapsin I (3 - 13) - (5-FAM) labeled
<strong>Synapsin I (3 - 13) - (5-FAM) labeled</strong>_x000D_ <strong>Catalog number:</strong> B2019472_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1784.9_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> 5-FAM-YLRRRLSDSNF_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Brigadski T, Hartmann M, Lessmann V. Differential vesicular targeting and time course of synaptic secretion of the mammalian neurotrophins J Neurosci. 2005 Aug 17;25(33):7601-14._x000D_ 2: Mukhamedyarov MA, Khabibrakhmanov AN, Khuzakhmetova VF, Giniatullin AR, Zakirjanova GF, Zhilyakov NV, Mukhutdinova KA, Samigullin DV, Grigoryev PN, Zakharov AV, Zefirov AL, Petrov AM. Early Alterations in Structural and Functional Properties in the Neuromuscular Junctions of Mutant FUS Mice Int J Mol Sci. 2023 May 19;24(10):9022._x000D_ 3: Li AJ, Suzuki S, Suzuki M, Mizukoshi E, Imamura T. Fibroblast growth factor-2 increases functional excitatory synapses on hippocampal neurons Eur J Neurosci. 2002 Oct;16(7):1313-24._x000D_ 4: Egashira Y, Mori Y, Yanagawa Y, Takamori S. Development of lentiviral vectors for efficient glutamatergic-selective gene expression in cultured hippocampal neurons Sci Rep. 2018 Oct 11;8(1):15156._x000D_ 5: Stöber G, Meyer J, Nanda I, Wienker TF, Saar K, Knapp M, Jatzke S, Schmid M, Lesch KP, Beckmann H. Linkage and family-based association study of schizophrenia and the synapsin III locus that maps to chromosome 22q13 Am J Med Genet. 2000 Jun 12;96(3):392-7._x000D_ 6: Moore RC, Chattillion EA, Ceglowski J, Ho J, von Känel R, Mills PJ, Ziegler MG, Patterson TL, Grant I, Mausbach BT. A randomized clinical trial of Behavioral Activation (BA) therapy for improving psychological and physical health in dementia caregivers: results of the Pleasant Events Program (PEP) Behav Res Ther. 2013 Oct;51(10):623-32._x000D_ 7: Porter LS, Porter BO, McCoy V, Bango-Sanchez V, Kissel B, Williams M, Nunnewar S. Blended Infant Massage-Parenting Enhancement Program on Recovering Substance-Abusing Mothers' Parenting Stress, Self-Esteem, Depression, Maternal Attachment, and Mother-Infant Interaction Asian Nurs Res (Korean Soc Nurs Sci). 2015 Dec;9(4):318-27._x000D_ 8: de Arcos FA, Verdejo García A, López Jiménez A, Montañez Pareja M, Gómez Juárez E, Arráez Sánchez F, Pérez García M. [Emotional response to affective stimuli in subjects addicted to opiates engaged in controlled use as part of the P.E.P.S.A] Adicciones. 2008;20(1):27-35._x000D_ 9: Sakamoto S, Kawasaki H, Kudo T, Kimura T, Yasuda H. [Application of non-invasive methods to assessment of left ventricular function in cardiomyopathy (author's transl)] Hokkaido Igaku Zasshi. 1977 Jan;52(1):51-7._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/26527276">10: Li S, Swanson SK, Gogol M, Florens L, Washburn MP, Workman JL, Suganuma T. Serine and SAM Responsive Complex SESAME Regulates Histone Modification Crosstalk by Sensing Cellular Metabolism Mol Cell. 2015 Nov 5;60(3):408-21. </a>_x000D_ _x000D_ <strong>Products Related to Synapsin I (3 - 13) - (5-FAM) labeled can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>
Product Specifications
Short Description
Catalog Number: B2019472 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog